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Lytic reactions of drugs with lipid membranes†
Hannah M. Britt,a Clara A. Garc´ıa-Herrero, a Paul W. Denny, b Jackie A. Mosely a
and John M. Sanderson *a
Propranolol is shown to undergo lipidation reactions in three types of lipid membrane: (1) synthetic single-
component glycerophospholipid liposomes; (2) liposomes formed from complex lipid mixtures extracted
from E. coli or liver cells; and (3) in cellulo in Hep G2 cells. Fourteen diﬀerent lipidated propranolol
homologues were identiﬁed in extracts from Hep G2 cells cultured in a medium supplemented with
propranolol. This isolation of lipidated drug molecules from liver cells demonstrates a new drug reactivity
in living systems. Acyl transfer from lipids to the alcoholic group of propranolol was favoured over
transfer to the secondary amine. Migration of acyl groups from the alcohol to the amine was diminished.
Other drugs that were examined did not form detectable levels of lipidation products, but many of these
drugs did aﬀect the lysolipid levels in model membranes. The propensity for a compound to induce
lysolipid formation in a model system was found to be a predictor for phospholipidosis activity in cellulo.
Introduction
Lipids are the key component of many materials, including
liposomes used in technology applications and the membranes
of cells and organelles in biological systems. In this article we
examine whether organic molecules that partition into
membranes, such as propranolol (1), can undergo direct
chemical reactions with lipids (Scheme 1). Demonstration of
such reactivity between membrane lipids and membrane-
associated drugs in vivo would constitute a signicant addi-
tion to our understanding of membrane chemistry. Reactivity of
this nature is likely to lead to biological eﬀects that may account
for the adverse activities of some drugs and the unusual phar-
macokinetic proles of others. By contrast, exploiting this
reactivity could oﬀer opportunities for the purposeful design of
new membrane-active compounds. The direct transfer of acyl
groups from membrane lipids to suitably disposed molecules
embedded within the membrane has a precedent, having been
demonstrated for peptides in vitro.1–3 In these cases, peptide
lipidation results from the high aﬃnity of the peptide for the
membrane, combined with the appropriate positioning of
reactive groups in the membrane interface. These aminolysis
reactions involve nucleophilic attack on a lipid ester group by
a suitably disposed nucleophile on the peptide, typically a lysine
3-amino group or the N-terminal amino group, and lead to the
formation of a lysolipid alongside the lipidated peptide.1 When
the nucleophile is a serine hydroxyl group, the process is
formally a transesterication. More recently, evidence has
emerged to suggest that some membrane proteins may also be
lipidated by direct transfer from the membrane. For example,
the lipidation prole of the lens protein aquaporin-0 has been
found to be highly complex.4 Aquaporin-0 has two lipidation
sites that do not correspond to known consensus sequences for
lipidation enzymes and are partially lipidated with numerous
diﬀerent acyl groups, with typically up to eight identiable. The
relative abundance of the acyl modications at each site
correlates with the acyl ester content of the lipids in the plasma
Scheme 1 Lipidation reactions involving propranolol. Key: HG,
headgroup.
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membrane leaet proximal to the site. Whilst these observa-
tions are not direct proof that this protein is lipidated by
transfer from the membrane, they do give a strong indication
that acyl transfer from the membrane is likely to be signicant
in vivo. Fundamentally, aquaporin-0 is a moderately high
molecular weight protein that is permanently membrane-
embedded in vivo, whilst peptides such as melittin that are
lipidated in vitro are of medium molecular weight with modest
membrane aﬃnity. It is therefore of key interest to establish
whether low molecular weight organic molecules, with
concomitantly lower membrane aﬃnity, are able to undergo the
same process. We selected the b-blocker propranolol to probe
this reactivity as it has both alcoholic and amine functionalities
alongside well-characterised membrane binding characteris-
tics.5–7 Furthermore, synthetic versions of O- and N-acyl
propranolol derivatives have been described as prodrugs,8–11
providing precedents for understanding their properties in vitro
and synthesising reference compounds for this work. In addi-
tion, propranolol is known to induce phospholipidosis,12,13 an
adverse activity associated with disorders in lysosomal phos-
pholipid storage, characterised by the formation of lamellar
bodies visible by microscopy of susceptible cells.14–20 In prin-
ciple therefore, propranolol may undergo both aminolysis and
transesterication reactions, both of which lead to the forma-
tion of lysolipids, as shown in Scheme 1 for reaction with the
acyl group at the sn-1 position of the lipid (although reaction
can occur at either the sn-1 or sn-2 position). The lysolipid
product would be formed as an equilibrium mixture of the 1-
and 2-acyl species.1 All of the products could be reasonably ex-
pected to display signicant biological activity as a consequence
of the presence of a fatty acyl chain. Lysolipids in particular, are
capable of inducing signicant deleterious biological eﬀects at
levels as low as 1 mol%.21
Lysolipids can also be formed by lipid hydrolysis, with
concomitant formation of a fatty acid. Membrane-associated
drugs have the potential to inuence the rate of this hydro-
lysis by either changing the bulk properties of the membrane,
mediated by secondary eﬀects on interfacial water activity, or by
direct involvement in acid or base catalysis.22,23 This article
describes the propensity of a number of membrane-active drugs
to undergo direct lipidation reactions with membrane lipids, or
promote other lytic reactions of lipids.
Experimental
Materials
Phospholipids and lysolipids, including E. coli Extract Polar
(catalogue number 100600P) and Liver Polar Lipid Extract
(Bovine, catalogue number 181108P) were purchased as
powders from Avanti Polar Lipids (via Instruchemie B.V., The
Netherlands). Propranolol was used as a racemic mixture.
Liposome preparation and sample set up
Liposomes were prepared by extrusion of lipid dispersions 10
through polycarbonate lters (Whatman) with 100 nm track-
etched pores, using a LIPEX thermobarrel extruder (Northern
Lipids Inc., BC, Canada). All experiments were conducted at
concentrations of 1.27 mM for lipids and (when present)
0.127 mM for membrane binding compounds. Using published
partitioning data5 these concentrations produce a bound
propranolol to lipid ratio of about 1 : 30. Samples at pH 7.4 were
buﬀered using bicarbonate at a NaCl concentration of 90 mM.
Calibration curves for analyte concentration were generated by
tting a logistic model to data obtained using authentic stan-
dards of lysolipids, propranolol and acyl propranolol derivatives
at known concentrations.
Hep G2 culture and extraction
Hep G2 cells from ATCC were grown to conuence at 37 C, 5%
CO2, and 95% humidity in Dulbecco's Modied Eagle Medium
(DMEM) with 10% foetal bovine serum (Gibco/ThermoFisher).
Cells (106) were incubated at 37 C, 5% CO2, and 95%
humidity overnight to adhere. The medium was removed and
replaced with either fresh medium (5 mL) for two controls, or
medium containing 30 mM propranolol (5 mL). Following
incubation for 72 h, the medium was removed from asks and
replaced with phosphate buﬀered saline (5 mL). Cells were
collected by centrifugation for 10 min at 1000 g, and decanted
into a glass tube before extraction with CHCl3 : MeOH (2 : 1; 3
mL). The CHCl3 : MeOH solution was washed with H2O (0.6
mL), isolated, and the solvent removed in vacuo. Samples were
resuspended in IPA : MeCN : H2O for liquid chromatography-
mass spectrometry (LC-MS) analysis.
Mass spectrometry
LC-MS was conducted on a Synapt G2-S (Waters Corp., UK)
using electrospray ionisation. LC was conducted using an Acq-
uity UPLC with a CSH C18 1.7 mm (2.1  150 mm) column with
solvent A¼H2O : MeCN 4 : 6 and B¼MeCN : iPrOH, 1 : 9 (both
A and B containing 10 mM NH4HCO2 + 0.1% formic acid) and
the following A : B gradient: 60 : 40 to 57 : 43 over 2 min, 57 : 43
to 50 : 50 over 0.1 min, 50 : 50 to 46 : 54 over 9.9 min, 46 : 54 to
30 : 70 over 0.1 min, 30 : 70 to 1 : 99 over 5.9 min. MS data were
processed using the instrument manufacturers soware (Mas-
sLynx, version 4.1) and the xcms package (version 1.52.0)24 in
the R statistical computing environment (version 3.4.1).25
Full methods are in the ESI.†
Results and discussion
Propranolol lipidation in liposomes composed of single lipids
and binary mixtures
Our initial objective was to establish that incubation of
propranolol (1) with liposomes could lead to the generation of
lipidated propranolol products. We were able to obtain unam-
biguous evidence for propranolol lipidation through the use of
liposomes with well-dened lipid compositions and compar-
ison of the lipidated products with authentic standards
prepared chemically. At 37 C and pH 7.4, using liposomes
composed of either 1-palmitoyl-2-oleoyl-sn-glycero-3-
phosphocholine (POPC, Fig. 1a) or 1,2-dioleoyl-sn-glycero-3-
phosphocholine (DOPC, Fig S1b†), lipidated propranolol (2
Chem. Sci. This journal is © The Royal Society of Chemistry 2018
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and 3, Scheme 1) was detectable in both cases, alongside
increased levels of lysolipid. Lysolipids were found in both
samples as a mixture of 1- and 2-oleoyl-sn-glycero-3-
phosphocholine (OPC), in addition to 1- and 2-palmitoyl-sn-
glycero-3-phosphocholine (PPC) in the case of POPC. The
predominant products in both cases arose from a trans-
esterication reaction involving the alcoholic group of
propranolol to form the O-acyl product (2). O- and N-acyl
modications to propranolol were distinguishable by the
shorter retention times for O-acyl propranolol derivatives in
comparison to their N-acyl counterparts (Fig. 1a and S1†) and by
their fragmentation patterns in tandem mass spectra produced
by collision-induced decay (CID). The CID MSMS spectra of O-
acyl propranolol (2) yielded a fragment of m/z 260, with species
of m/z 155 and m/z 183 having the highest relative abundance
(Fig. 1b and S1–S3, Table S1†). In contrast, N-acyl propranolol
homologues (3) were particularly notable for the high relative
abundance of fragments with an intact acyl chain, at m/z 338
and m/z 380 for N-oleoyl propranolol, alongside a high relative
abundance for the fragment at m/z 260 corresponding to the
loss of the acyl chain (Fig. 1c, S4, Tables S2 and S3†).
Aer instrument calibration, using data from authentic
standards to convert raw ion intensities to concentrations
(Fig. S5, Table S4†), the concentrations of both total lipidated
propranolol and lysolipid are seen to increase steadily over the
rst 48 h following mixing (Fig. 2). At these early time points,
the predominant lipidated product is the O-acyl ester (Fig. S6†).
The concentration of the N-acyl amide exhibits a small latency
period before concentrations begin to increase, which indicates
that the N-acyl product may be formed by O to N migration of
the acyl group rather than direct aminolysis of the lipid. Such
a migration has been described in the literature for propranolol
ester derivatives in solution.8,10
The data are reproducible at time points up to 48 h, but show
greater sample-to-sample variability over longer periods,
particularly for the concentration of lysolipid. Aer 72 h the
total content of lipidated propranolol decreases, the reasons for
which are not currently understood, although hydrolysis or
insolubility of one or both of the acyl derivatives are likely
causes. Consequently, only data obtained within the rst 48 h
have been used for comparative analyses. As indicated in
Fig. 1a, acyl transfer to propranolol from the lipid is expected to
lead to the formation of a stoichiometric equivalent of lysolipid,
which should lead to identical concentration changes for acyl
propranolol and lysolipid, assuming that there are no
competing processes. For DOPC, a linear t to the data over the
rst 48 h gave a rate of acyl propranolol formation of 8.7 (2.8)
 105 mM h1, which was 0.6 (0.3) times the rate of lysolipid
formation in the same period. This indicates that either
propranolol binding changes bilayer properties to facilitate
hydrolysis, or that propranolol is able to catalyse lipid hydro-
lysis in addition to undergoing transesterication reactions.
The lipidated propranolol products themselves may also
promote lipid hydrolysis, for example by inducing changes to
membrane properties that modify interfacial water activity, or
by direct involvement in acid–base catalysis.
Propranolol lipidation in lipid extracts
Having demonstrated lipidation of propranolol in vitro, it was of
fundamental interest to probe whether this reaction also
occurred in cellulo. In order to address this question propran-
olol was rst incubated with liposomes composed of commer-
cial lipid mixtures extracted from E. coli or liver cells (Fig. S7†)
so that the likelihood of lipidation occurring in complex
membranes could be assessed and the scale of the analytical
challenge understood, given the likely complexity of the
products.
In both of these experiments, the ability to identify lipidation
products was conrmed, with each extract yielding a series of
acyl-modied derivatives (Fig. 3a, S8, Tables 1 and S5†) with
Fig. 2 Product formation following the addition of propranolol (0.127
mM) to DOPC liposomes (1.27 mM) at pH 7.4, 37 C. The total
concentration of oleoyl propranolol (N- plus O-oleoyl) is shown as
blue triangles. The lysolipid concentration, shown as magenta circles,
is the concentration (1- plus 2-oleoyl) after subtraction of the lysolipid
concentration in a control sample without propranolol. The inset
shows a magniﬁed view of the ﬁrst data points. Errors are mean  s,
n ¼ 3.
Fig. 1 LC-MS analysis of lipidated products formed after addition of
propranolol to POPC membranes. LC separation (A) was conducted on
aC18 column using the protocol outlined in themethods section. (B) CID
MSMS spectrum ofO-oleoyl propranolol. (C) CID MSMS spectrum ofN-
oleoyl propranolol. Spectra for the corresponding palmitoyl products
are in Fig. S2.† For assignments, see Tables S1–S3 and Fig. S3, S4.†
This journal is © The Royal Society of Chemistry 2018 Chem. Sci.
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relative abundances qualitatively in line with those expected
based on the fatty acid prole of the extract, including modi-
cations with cyclopropyl fatty acids for the E. coli extract and
a high relative abundance for stearoyl-modied propranolol for
the liver extract. Details of the lipid species identied are in the
ESI (Tables S6 and S7†). Some products anticipated on the basis
of the relative fatty acid abundances were not observed,
including modication with C22:5. A number of reasons could
account for the failure to observe these products, including
their presence at concentrations below the detection limit,
diﬀerences in the fatty acid prole of the commercial mixture
from published data, peak overlap leading to ion suppression,
and their presence in a form that is not reactive.
Propranolol lipidation in cellulo
With knowledge that acylated propranolol derivatives could be
identied in complex mixtures of natural lipids, propranolol
lipidation in cellulo was probed. The Hep G2 cell line was
selected for this work in order to build on the data described
above for liver cell extracts and because propranolol is known to
induce phospholipidosis (PLD) in Hep G2 cells with an EC50
between 12.6 and 16 mM.13 In our hands, incubation of Hep G2
Fig. 3 Overlaid extracted ion chromatograms (EICs) of the molecular
ions corresponding to the lipidated propranolol species formed by
incubation of propranolol with liver lipids. (a) Liposomes formed from
bovine liver extract ([M + H]+; calculated m/z  6 ppm). (b) Acyl
modiﬁed propranolol derivatives extracted from Hep G2 cells cultured
in amedium containing 30 mMpropranolol ([M + H]+; calculatedm/z
7 ppm).
Table 1 Fatty acid proﬁles of bovine liver and Hep G2 phospholipids
and the acylated propranolol derivatives observed by LCMS analysis
after either propranolol (1) incubation with bovine liver extract lipo-
somes, or the growth of Hep G2 cells for 72 h in the presence of
propranolol (1)
Source
Fatty
acid
Abund.a
(%) Observed m/zb
Errorc
(ppm)
Liver extract 14 : 0 — 470.3618 3.4
16 : 0 11 498.3947 0.0
18 : 0 29 526.4276 3.0
18 : 1 10 524.4099 0.9
18 : 2 8 522.3951 0.7
20 : 3 4 548.4109 1.0
20 : 4 16 546.3932 2.8
22 : 4 2 574.4227 5.8
Hep G2 cells 14 : 0 6.4 470.3637 +0.6
16 : 0 33.4 498.3940, 498.3937f 1.4, 2.0f
16 : 1 13.8 496.3762 5.8
18 : 0 5.7 526.4266 +1.2
18 : 1 31.5d 524.4106, 524.4132f +0.4, +5.4f
18 : 2 0.7 522.3971, 522.3934f +4.6, 2.4f
20 : 1 0.7 552.4423 +1.1
20 : 2e — 550.4255 0.9
20 : 3e — 548.4078 4.7
20 : 4e 1.0 546.3949 +0.4
22 : 6 0.8 570.3966 +3.3
a Proportion (mol%) of each fatty acyl chain found in total bovine liver
phospholipids26 or in lipids isolated from Hep G2 cells cultured in the
absence of propranolol in a medium containing 10% foetal bovine
serum.27 Some fatty acids reported in this study were not found as
modications to propranolol, including C18:3 (0.09 mol%), C20:5
(0.31 mol%) and C22:5 (0.92%). b Observed m/z of acyl propranolol
following fatty acyl transfer from the lipid. Data are for the O-acyl
species unless otherwise stated. c Error between observed and
calculated m/z for [M + H]+ following transfer of this fatty acid to
propranolol. d Comprises 18:1n-7 (12.5%) and 18:1n-9 (19.0%). e Not
shown in Fig. 3b. Retention times: 192 s (20:4); 224 s (20:3); 247 s
(20:2). f N-Acyl (amide).
Fig. 4 Tandem mass spectrometry analysis of samples extracted from
Hep G2 cells cultured in a medium containing propranolol. (a) Extracted
ion chromatograms (EICs) of product ions formed by targeted CID frag-
mentation of the ions withm/z 498.396 (magenta) andm/z 524.411 (blue),
corresponding to [M + H]+ for palmitoyl propranolol and oleoyl propran-
olol respectively. A target mass window of 4m/z was used for CID. The
chromatograms in (a) are the sumof themonoisotopic EICs for each ion in
Fig. S3 and S4† with a mass window of 8 ppm. Panels (b) and (c) show
individual mass spectra corresponding to the indicated peaks in (a).
Chem. Sci. This journal is © The Royal Society of Chemistry 2018
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cells with 30 mM propranolol induced PLD as expected
(Fig. S9†). By performing tests with POPC liposomes beforehand
(Fig. S10†), the use of a chloroform/methanol mixture for the
chemical extraction of Hep G2 cells was veried as the best
approach for recovering both O- and N-acyl propranolol deriv-
atives. When compared with the starting liposome mixture,
a partial reduction in the relative intensity of O-oleoyl
propranolol was found in the extracts, indicating a reduced
extraction eﬃciency for propranolol modied with unsaturated
fatty acyl groups. However, in the worst-case scenario all species
could at least be partially recovered. Extraction of Hep G2 cells
by this approach, followed by LC-MS analysis, identied a range
of lipids (Fig. S11, Table S8†) alongside 14 diﬀerent lipidated
propranolol species (Fig. 3b, Table 1).
The predominant fatty acyl modications to propranolol
observed in the chromatograms, palmitoyl and oleoyl (Table 1),
were those anticipated on the basis of published fatty acid
proles for Hep G2 cells cultured in the same medium,
considered alongside the diﬀerences in extraction eﬃciency
discussed above. The identities of some of the lipidated
propranolol species were further conrmed by LC-MSMS anal-
ysis of the Hep G2 extract, with the palmitoyl- and oleoyl-
modied propranolol parent species targeted for fragmenta-
tion (Fig. 4). As evidenced by the relatively early retention times
and a high relative abundance of product ions with m/z 155 and
m/z 183, the predominant products were O-acyl propranolol
derivatives. Only trace quantities of the N-acyl species could be
detected (Fig. 4, peaks iii and vii). The CID target mass window
was suﬃciently wide to conrm the presence of other related
species in the mixture, including O-palmitoleoyl (Fig. 4, peak i),
O-linoleoyl (peak iv) and O-stearoyl propranolol (peak vi).
In contrast to the experiments with extracted lipid mixtures,
the reactivity of propranolol in Hep G2 membranes might be
expected to produce a response that is inuenced by the pres-
ence of lipid homeostasis in the cell. Indeed signicant diﬀer-
ences were found in the intensities of some lipids when
comparing cells cultured with or without propranolol (Table
S9†). These included decreases in the levels of some triglycer-
ides and phosphatidylserine, and striking increases in the levels
of ether-linked lipids, which would have the eﬀect of reducing
the ester content of the membrane that is transferrable in
intrinsic lipidation reactions.
The biological eﬀects of drug lipidation
As we had evidence that propranolol reacts with membrane
lipids both in vitro and in vivo, leading to the generation of
lysolipids and a lipidated drug, it was of fundamental interest to
establish whether this reactivity had the potential to induce
detectable physiological eﬀects. Previous work has established
that some classes of drug linked with phospholipidosis are able
to promote lipid hydrolysis inmodel systems in vitro, potentially
by acting as phase transfer catalysts.22,23 We therefore explored
whether propranolol and other compounds known to induce
phospholipidosis (Fig. 5) were subject to lipidation in a model
Fig. 5 Drug molecules studied in this work in addition to propranolol
(1).
Fig. 6 (a) Evolution of the 1/2-oleoyl-sn-glycero-3-phosphocholine (OPC) concentration in liposomes composed of DOPC (1.27 mM) following
exposure to diﬀerent drugs (0.127mM) at pH 7.4 and 37 C. Errors aremean s, n¼ 3. Rawdata are shown as points, linear ﬁts to the reaction rate over
the ﬁrst 24 h as lines. (b) Relationship between the rate of lysolipid formation in DOPC and phospholipidosis activity12,13 for each of the drugs in part (a).
This journal is © The Royal Society of Chemistry 2018 Chem. Sci.
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DOPC system or otherwise inuence the levels of lysolipid, and
examine the correlation between these activities and phospho-
lipidosis activity. Interestingly, only propranolol underwent any
lipidation reactions in DOPC membranes. However, all of the
compounds with appreciable phospholipidosis activity yielded
detectable increases in the initial rate of lipid hydrolysis over
24 h (Fig. 6a) compared to a control in the same conditions
without compound. It may be the case that the amino group of
propranolol is positioned in such a manner that it can promote
the transesterication reactions of propranolol, but in the
absence of proximal acyl group acceptor, the amino groups of
the other drugs favour reactions involving interfacial water.
Although there is a correlation between phospholipidosis
activity and hydrolysis rates, with for example uoxetine
producing the fastest rate of lipid hydrolysis and having the
lowest EC50 (Fig. 6b), the relationship is not simple, as indicated
by the non-linearity in Fig. 6b.
It might be expected that both the lipidated drug and the
lysolipid have the potential to disrupt lipid membranes as
a consequence of their shape, which favours detergent-like
activity. Both N-oleoyl and N-palmitoyl propranolol were
found to havemeasurable micelle-forming behavior, with CMCs
of 9 mM and 10 mM respectively (Fig. S12†). Addition of both of
these N-acyl compounds at a concentration of 1 mol% to POPC
liposomes loaded with the markers 8-aminonaphthalene-1,3,6-
trisulfonic acid (ANTS, 12.5 mM) and p-xylene-bis-pyridinium
bromide (DPX, 45 mM) resulted in the loss of membrane
integrity with concomitant increase in uorescence (Fig. S13†).
Similar results were obtained for monooleoyl and monop-
almitoyl PC. Parallel analyses using O-acyl species proved to be
problematic due to the rapid hydrolysis of these species in the
absence of membranes.
Conclusions
This work has demonstrated the fundamental point that low
molecular weight organic molecules are capable of generating
lytic chemical processes in lipid membranes, including direct
intermolecular reactions such as transesterication, or the
promotion of other reactions such as hydrolysis. However, as
evidenced by the reactivity of propranolol in comparison to
drugs such as uoxetine and sertraline, the selectivity for lip-
idation vs. hydrolysis is complex and most likely linked to
a number of factors, including the molecular disposition in the
membrane interface, the distribution prole (log D) and the pKa
values of any ionisable groups. Furthermore, it is clear that the
activities observed in vitro are also likely to occur in vivo. This
has been demonstrated directly by the observation of the
products of lipidation reactions of propranolol in Hep G2 cells
and indirectly by correlations between the hydrolysis promoting
activity of drugs in vitro and their EC50 for phospholipidosis. In
the case of propranolol it is also striking that the O-acyl esters,
which normally rapidly rearrange to the N-acyl amide counter-
part in vitro, exhibit increased stability in the membrane envi-
ronment. This observation highlights the fact that there is
much concerning the chemistry that occurs in the membrane
interface that remains to be understood.
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